Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
What's New
Your Valuation
Loading...
Community
/
United States
/
Pharmaceuticals & Biotech
/
Protagonist Therapeutics
Create a narrative
Protagonist Therapeutics Community
NasdaqGM:PTGX Community
0
Narratives
written by author
0
Comments
on narratives written by author
13
Fair Values set
on narratives written by author
Community Investing Ideas
Protagonist Therapeutics
Popular
Undervalued
Overvalued
There are no community narratives available.
Your Valuation for
PTGX
PTGX
Protagonist Therapeutics
Your Fair Value
US$
Current Price
US$77.50
37.4% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-138m
576m
2015
2018
2021
2024
2025
2027
2030
Revenue US$576.4m
Earnings US$143.4m
Advanced
Set Fair Value